Publications by authors named "David N Cade"

Claim this Profile
S
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Guy A van Hazel, Volker Heinemann, Navesh K Sharma, Michael P N Findlay, Jens Ricke, David N Cade

J Clin Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
Peter Gibbs, Cuong Do, Lara Lipton, David N Cade, Michael J Tapner

BMC Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth Thurston, David N Cade

BMC Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis